We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UPS:NYSEUnited Parcel Service, Inc. Analysis

Data as of 2026-05-07 - not real-time

$100.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

UPS is trading around $100, comfortably above its 20‑day ($104), 50‑day ($102) and 200‑day ($97) simple moving averages, indicating a bullish price trend, yet the MACD histogram is negative and the RSI sits near 44, suggesting limited upside momentum and a neutral stance. Volatility is elevated at over 42% for the past 30 days and beta is close to 1, pointing to market‑wide risk exposure. The stock offers a high dividend yield of 6.57% but the payout ratio exceeds 100%, raising concerns about dividend sustainability.
Fundamentally, revenue has slipped 1.6% year‑over‑year, margins remain modest (gross 22%, operating 6.3%), and ROE is strong at 33%, while leverage is high with a debt‑to‑equity of 181. The DCF fair value of roughly $47 is far below the current price, flagging potential overvaluation despite an industry PE average of 30 versus UPS’s 16. Recent earnings beat was tempered by comments on rising fuel costs, competitive pressure from Amazon’s supply‑chain services, and a “hold” rating from some analysts, underscoring a mixed near‑term outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages but MACD bearish
  • Elevated short‑term volatility
  • Unsustainable dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue contraction and high leverage
  • Strong cash flow generation offset by competitive pressures
  • Valuation gap between market price and DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust ROE and cash flow supporting strategic investments
  • Secular growth in e‑commerce and logistics demand
  • Potential price correction aligning market price with intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth-1.60%
Profit Margin5.94%
P/E Ratio16.2
ROE33.35%
ROA7.27%
Debt/Equity181.51
P/B Ratio5.2
Op. Cash Flow$8.4B
Free Cash Flow$4.7B
Industry P/E30.1

Technical Analysis

TrendBullish
RSI44.4
Support$95.98
Resistance$109.84
MA 20$104.25
MA 50$102.33
MA 200$97.41
MACDBearish
VolumeIncreasing
Fear & Greed Index90.93

Valuation

Fair Value$46.88
Target Price$113.00
Upside/Downside12.89%
GradeOvervalued
TypeValue
Dividend Yield6.57%

Risk Assessment

Beta0.93
Volatility42.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.